498 ES015, a first-in-class NKG2A and NKG2C dual-targeting antibody, demonstrated potent anti-tumor immune response
oleh: Rui Gao, Jing Gao, Chunnian Wang, Dawei Sun, Hongtao Lu, Wenqiang Lu, Quan Qiu, Jingfeng Yu, Zeyu Liu, Hongping Zhou
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2023-11-01 |
Deskripsi
No description available for this item.